Publications by authors named "Toshimi Takano"

90Publications

[Hypopituitarism].

Gan To Kagaku Ryoho 2020 Jun;47(6):885-890

Dept. of Medical Oncology, Toranomon Hospital.

View Article

Download full-text PDF

Source
June 2020

[Malignant Spinal Cord Compression].

Gan To Kagaku Ryoho 2020 Jun;47(6):875-880

Dept. of Medical Oncology, Toranomon Hospital.

View Article

Download full-text PDF

Source
June 2020

The era of meta-analyses-based recommendations: how were the Japanese Breast Cancer Society Clinical Practice Guidelines for Systemic Treatment of Breast Cancer established?

Authors:
Toshimi Takano

Breast Cancer 2020 05;27(3):332-333

Breast Medical Oncology Department, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-020-01099-8DOI Listing
May 2020

Risks and benefits of bevacizumab combined with chemotherapy for advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials.

Breast Cancer 2020 May 23;27(3):347-354. Epub 2020 Jan 23.

Department of Breast Oncology, Aichi Cancer Center, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-020-01052-9DOI Listing
May 2020

Sacituzumab Govitecan-hziy in Triple-Negative Breast Cancer.

N Engl J Med 2019 06;380(24):2382

Toranomon Hospital, Tokyo, Japan

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1903943DOI Listing
June 2019

[I. Dose-Dense Chemotherapy as Perioperative Treatment in Breast Cancer].

Gan To Kagaku Ryoho 2017 Dec;44(13):2073-2076

Dept. of Medical Oncology, Toranomon Hospital.

View Article

Download full-text PDF

Source
December 2017

Phenotypical change of tumor-associated macrophages in metastatic lesions of clear cell renal cell carcinoma.

Med Mol Morphol 2018 Mar 7;51(1):57-63. Epub 2017 Dec 7.

Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuouku, Kumamoto, 860-8556, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00795-017-0174-7DOI Listing
March 2018

[Heart failure].

Nihon Rinsho 2015 Feb;73 Suppl 2:389-98

View Article

Download full-text PDF

Source
February 2015

Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype.

BMC Cancer 2014 Dec 16;14:964. Epub 2014 Dec 16.

Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-14-964DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301945PMC
December 2014

Resistance to androgen-pathway drugs in prostate cancer.

N Engl J Med 2014 12;371(23):2233-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1412594DOI Listing
December 2014

The safety of chemotherapy for colorectal cancer patients with hepatitis C virus infection.

Med Oncol 2014 Oct 20;31(10):212. Epub 2014 Sep 20.

Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-014-0212-4DOI Listing
October 2014

Intratumoral distribution of EGFR-amplified and EGFR-mutated cells in pulmonary adenocarcinoma.

Pathol Res Pract 2014 Mar 28;210(3):155-60. Epub 2013 Nov 28.

Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prp.2013.11.008DOI Listing
March 2014

Treatment of acute promyelocytic leukemia.

N Engl J Med 2013 10;369(15):1471-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1309895DOI Listing
October 2013

Reduction of toxicity by reversing the order of infusion of docetaxel and cyclophosphamide.

Chemotherapy 2013 31;59(2):93-8. Epub 2013 Aug 31.

Department of Breast and Endocrine Surgery, Toranomon Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000351112DOI Listing
May 2014

Radiation-induced esophagitis exacerbated by everolimus.

Case Rep Oncol 2013 May 15;6(2):320-4. Epub 2013 Jun 15.

Departments of Medical Oncology, Toranomon Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000353309DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725027PMC
May 2013

Validation study of a prognostic classification in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapy.

J Cancer Res Clin Oncol 2013 Apr 19;139(4):595-603. Epub 2012 Dec 19.

Department of Gastrointestinal Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-012-1349-1DOI Listing
April 2013

Olaparib in platinum-sensitive ovarian cancer.

N Engl J Med 2012 07;367(2):179; author reply 179-80

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/abs/10.1056/NEJMc1205423
Publisher Site
http://dx.doi.org/10.1056/NEJMc1205423DOI Listing
July 2012

Colorectal-cancer screening.

N Engl J Med 2012 05;366(22):2129; author reply 1230-1

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1203544DOI Listing
May 2012

Adjuvant trastuzumab in HER2-positive breast cancer.

N Engl J Med 2012 02;366(7):663; author reply 664-6

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/abs/10.1056/NEJMc1112823
Publisher Site
http://dx.doi.org/10.1056/NEJMc1112823DOI Listing
February 2012

Exemestane for breast-cancer prevention.

N Engl J Med 2011 09;365(11):1056-7; author reply 1057-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1108287DOI Listing
September 2011

Early prostate cancer--treat or watch?

N Engl J Med 2011 08;365(6):568-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1106325DOI Listing
August 2011

Cabazitaxel for castration-resistant prostate cancer.

Lancet 2011 Jan;377(9760):121; author reply 122-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(11)60012-3DOI Listing
January 2011

Neoadjuvant chemotherapy or primary surgery in advanced ovarian cancer.

N Engl J Med 2010 12;363(24):2371; author reply 2372

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1011061DOI Listing
December 2010

Treatment of lung cancer.

Authors:
Toshimi Takano

N Engl J Med 2009 Dec;361(25):2485-6; author reply 2486-7

View Article

Download full-text PDF

Source
December 2009

EGFR mutations predict survival benefit from gefitinib in patients with advanced lung adenocarcinoma: a historical comparison of patients treated before and after gefitinib approval in Japan.

J Clin Oncol 2008 Dec 15;26(34):5589-95. Epub 2008 Sep 15.

Division of Internal Medicine, Research Center for Cancer Prevention and Screening, National Cancer Center Hospital, Tokyo 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.16.7254DOI Listing
December 2008

Proteomic signature corresponding to the response to gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma.

Clin Cancer Res 2007 Feb;13(3):799-805

Proteome Bioinformatics Project, National Cancer Center Research Institute, Department of Surgery, Tokyo Medical University, and Clinical Laboratory Division, National Cancer Center Hospital, Japan.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-06-1654DOI Listing
February 2007

Erlotinib in lung cancer.

N Engl J Med 2005 Oct;353(16):1739-41; author reply 1739-41

View Article

Download full-text PDF

Source
October 2005

[Doctor-initiated clinical trials and the revised pharmaceutical affairs law].

Gan To Kagaku Ryoho 2003 Oct;30(10):1391-7

Division of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

View Article

Download full-text PDF

Source
October 2003